Medtronic PLC
NYSE:MDT
Medtronic PLC
Revenue
Medtronic PLC
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Medtronic PLC
NYSE:MDT
|
Revenue
$33.2B
|
CAGR 3-Years
1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
7%
|
|
|
STERIS plc
NYSE:STE
|
Revenue
$5.1B
|
CAGR 3-Years
6%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
Medtronic PLC
Revenue Breakdown
Breakdown by Geography
Medtronic PLC
|
Total Revenue:
32.4B
USD
|
|
Total Other Countries, Excluding Ireland:
32.3B
USD
|
|
United States Pension Benefits:
16.6B
USD
|
|
Non-United States Developed Markets:
10B
USD
|
Breakdown by Segments
Medtronic PLC
|
Total Revenue:
32.4B
USD
|
|
Reportable Segment Net Sales:
32.1B
USD
|
|
Cardiovascular:
11.8B
USD
|
|
Neuroscience:
9.4B
USD
|
Medtronic PLC
Glance View
In the intricate world of medical technology, Medtronic PLC stands tall as one of the foremost innovators transforming the landscape of healthcare. Founded in 1949 as a humble medical supply repair shop in Minnesota, Medtronic has grown into a global titan, driven by the enduring mission to alleviate pain, restore health, and extend life. The company's breadth is vast, touching nearly every aspect of patient care, from advanced robotic-assisted surgery systems to sophisticated insulin pumps. At its core, Medtronic thrives on relentless research and development, continually bridging the gap between cutting-edge technology and practical medical solutions. By forging deep alliances with healthcare providers and systems around the globe, the company ensures its innovations are not only groundbreaking but also widely accessible. The company's financial engine purrs to life primarily through the development and sale of medical devices across four major segments: Cardiac and Vascular Group, Minimally Invasive Therapies, Restorative Therapies Group, and Diabetes Group. Each unit meticulously focuses on innovating and providing solutions relevant to its field, ensuring a diversified portfolio with robust pipelines. For instance, within the Cardiac and Vascular Group, Medtronic supplies life-saving products like pacemakers and stents while also exploring breakthrough therapies such as transcatheter heart valves. By capitalizing on a global presence, the company strategically taps into both mature markets in North America and Europe and emerging markets across Asia and Latin America, thereby driving substantial revenue streams. Through this multifaceted operational framework, Medtronic not only sustains its market dominance but also reinvests in the future of medical technology, symbolizing a perpetual cycle of growth and innovation.
See Also
What is Medtronic PLC's Revenue?
Revenue
33.2B
USD
Based on the financial report for Jan 24, 2025, Medtronic PLC's Revenue amounts to 33.2B USD.
What is Medtronic PLC's Revenue growth rate?
Revenue CAGR 10Y
7%
Over the last year, the Revenue growth was 3%. The average annual Revenue growth rates for Medtronic PLC have been 1% over the past three years , 1% over the past five years , and 7% over the past ten years .
You don't have any saved screeners yet